ALLIANCEBERNSTEIN L.P. - ORAMED PHARMACEUTICALS INC ownership

ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 57 filers reported holding ORAMED PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.0%.

Quarter-by-quarter ownership
ALLIANCEBERNSTEIN L.P. ownership history of ORAMED PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$144,000
-39.5%
16,7000.0%0.00%
Q4 2021$238,000
+8.2%
16,700
+67.0%
0.00%
Q3 2021$220,000
+64.2%
10,0000.0%0.00%
Q2 2021$134,000
+13300.0%
10,000
+18081.8%
0.00%
Q1 2014$1,000550.00%
Other shareholders
ORAMED PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Acrospire Investment Management LLC 8,355$61,0000.04%
TOCQUEVILLE ASSET MANAGEMENT L.P. 70,000$508,0000.01%
Financial Architects, Inc 2,000$15,0000.00%
FineMark National Bank & Trust 3,473$25,0000.00%
JFS WEALTH ADVISORS, LLC 1,000$7,0000.00%
Penserra Capital Management LLC 2,540$18,0000.00%
Tower Research Capital LLC (TRC) 1,284$10,0000.00%
SIMPLEX TRADING, LLC 2,673$19,0000.00%
Plante Moran Financial Advisors, LLC 300$2,0000.00%
Cutler Group LLC / CA 2,404$17,0000.00%
View complete list of ORAMED PHARMACEUTICALS INC shareholders